25 years experience in the field of radiopharmaceutical sciences.  Areas of expertise include development of new PET radiopharmaceuticals for research, diagnosis and for clinical trials; production and quality control of radiopharmaceuticals; metabolite analysis; cyclotron targets; good manufacturing practise (GMP); quality assurance; auditing; inspections.

Radiopharmaceuticals for neuroreceptor imaging with PET; radiopharmceuticals for diagnostic imaging in oncology; methods for measurement of radiometabolites; targets for the production of carbon-11 labelled gases; new methods for GMP compliant preparation of radiopharmaceuticals.

See above.